Polydex Pharmaceuticals Financials

Polydex Pharmaceuticals Stock Summary

Polydex Pharmaceuticals competes with ImmuCell, Senstar Technologies, Natural Alternatives, and Paragon Technologies. Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada. Polydex Pharm operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people.

Polydex Pharmaceuticals Key Financial Ratios

There are many critical financial ratios that Polydex Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Polydex Pharmaceuticals reports annually and quarterly.

Polydex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Polydex Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Polydex Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Polydex Pharmaceuticals competition to find correlations between indicators driving Polydex Pharmaceuticals's intrinsic value. More Info.Polydex Pharmaceuticals is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Polydex Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Polydex Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Polydex Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Polydex Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Polydex Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Polydex Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Polydex Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.